Original article

Impact of enhanced compliance initiatives on the efficacy of rosuvastatin in reducing low density lipoprotein cholesterol levels in patients with primary hypercholesterolaemia

R Dariolo

DOI: https://doi.org/10.4414/smw.2008.12120
Publication Date: 26.07.2008
Swiss Med Wkly. 2008;138(29-30):420-426

This text is only available as PDF .

Verpassen Sie keinen Artikel!

close